Pre-Conference Symposia (ISC)

Updated:Oct 4,2013
Stroke ISC 2015 Logo

Pre-Conference Symposia

The Pre-Conference Symposium of the International Stroke Conference is designed to provide up-to-date information for healthcare professionals caring for patients with stroke. This one-day symposium highlights scientific advances in cerebrovascular disease while emphasizing their application in the real world. This year’s symposium will focus on issues pertinent to the acute management of stroke in the ED and will cover a variety of topics of interest to healthcare providers working in the emergency department such as ED physicians, hospitalists, neurologists, nurses/nurse practitioners, physician assistants, stroke fellows, and pharmacists.

The main focus will be on identifying unusual presentations of stroke; reviewing data on the use of intravenous and intra-arterial therapy; field triage of stroke patients and the utilization of primary stroke centers; treating ICH, SAH and ischemic stroke during the golden hour in the ED; and managing complications of novel anticoagulants as well as a series of interactive breakout sessions. Participants will also have the opportunity to have an informal lunch with the faculty where questions or challenging stroke cases may be discussed.

Pre-Conference Symposium I Programming   |   Learning Objectives   |   Program Committee
CME Information


ISC 2014 Pre-Conference Symposium I: Stroke in the Real World: Emergency Stroke Care 2014

Tuesday, Feb 11
9:30 am – 5:00 pm

Moderators:  
 Theodore Wein, MD, FRCPC, FAHA, Montreal, QC, Canada
                      Joshua Goldstein, MD, PhD, FAHA, Boston, MA

9:30    Welcome
          Steven M Greenberg, MD, PhD, FAHA, Boston, MA

9:35    A Wolf in Sheep’s Clothing: Identifying Unusual Presentations of Stroke
         
Kama Guluma, MD, San Diego, CA

10:00  Q&A

10:08  Open Up Your Mind: Revascularization 2014

10:10  Open Up Your Mind: Intravenous Thrombolysis in 2014

10:25  Open Up Your Mind: Intrarterial Thrombolysis / Interventional Therapy 2014
         
Raul Nogueira, MD, Atlanta, GA

10:40  Open Up Your Mind: Decision Analysis in Thrombolytic Therapy
         
Michael Hill, MD, MSc, FRCPC, Calgary, AB, Canada

10:55  Q&A

11:05  Where Do We Go from Here? Triage in the Field
         
Prasanthi Govindarajan, MD, MAS, San Francisco, CA

11:20  Q&A

11:25  The New Batmobile: Putting the ED into the Ambulance
      
    Martin Ebinger, MD, Berlin, Germany

11:35  Q&A

11:40  Sue-sue-sue Ya! Medico Legal Issues in Stroke Care

11:55  Q&A

12:00  Stand By Me: Who’s Backing You Up?
          
Natalia S Rost, MD, MA, Boston, MA

12:12  Q&A

12:20 pm – 1:15 pm
Lunch with the Faculty: Ask Your Questions
All Faculty (A boxed lunch will be provided.)

1:15 pm – 3:00 pm

Moderators:  
Brett M Kissela, MD, MS, Cincinnati, OH
                      Kama Guluma, MD, San Diego, CA

1:15   Not Tonight; I Have a Headache
        
Peter Panagos, MD, St Louis, MO

1:30   Q&A

1:35   The Golden Hour

1:37   The Golden Hour: ICH in the ED
        
Opeolu Adeoye, MD, Cincinnati, OH

1:47   The Golden Hour: SAH in the ED
         
J Claude Hemphill III, MD, MS, FAAN, San Francisco, CA

1:57   The Golden Hour: Ischemic Stroke in the ED
          Laura Heitsch, MD, St Louis, MO

2:10 Q&A

2:20   NOACS in the ER: What You Really Need to Know
         Hans-Christoph Diener, MD, PhD, FAHA, FAAN, Essen, Germany

2:45   Q&A

3:00 pm – 3:45 pm   Concurrent Sessions

     Concurrent IA: The 5 Minute Neurological Exam
     
Theodore Wein, MD, FRCPC, FAHA, Montreal, QC, Canada     

     Concurrent IB: Dissecting Dizziness
     David Newman-Toker, MD, PhD, Baltimore, MD

     Concurrent IC: Are You Up to Snuff? Current Standard of Care for Treating TIA and Stroke
     
Mary Kalafut, MD, FAHA, La Jolla, CA

     Concurrent ID: Imaging and Thrombolysis Workshop
    
Andrew Demchuk, MD, Calgary, AB, Canada        

3:50 pm – 4:30 pm   Concurrent Sessions

     Concurrent IA: The 5 Minute Neurological Exam
     
Theodore Wein, MD, FRCPC, FAHA, Montreal, QC, Canada     

     Concurrent IB: Dissecting Dizziness
     David Newman-Toker, MD, PhD, Baltimore, MD

     Concurrent IC: Are You Up to Snuff? Current Standard of Care for Treating TIA and Stroke
     
Mary Kalafut, MD, FAHA, La Jolla, CA

     Concurrent ID: Imaging and Thrombolysis Workshop
    
Andrew Demchuk, MD, Calgary, AB, Canada        

4:35 pm
- 5:00 pm

4:35   Big Brother Is Watching
        
Joshua Goldstein, MD, PhD, FAHA, Boston, MA

4:50   Q&A

4:55   Closing Remarks
         Kyra Becker, MD, FAHA, Seattle, WA

Please note that there is a separate registration fee to attend the ISC Pre-Conference Symposium.


 
Learning Objectives

After participating in this activity, participants will be able to: 
 
  • Identify unusual presentations of stroke
  • Compare intravenous thrombolysis and intrarterial thrombolysis, and deduce which therapy is appropriate for each patient
  • Establish when to bypass the closest hospital, and when to transfer from your hospital to a comprehensive stroke center
  • Describe medico legal issues in stroke care and available telephone support/telestroke
  • Apply LP, CSF sensitivity, specificity of a negative CT, and/or CTA for differential diagnosis
  • Discuss ICH, SAH and ischemic stroke in the ED
  • Manage NOACS in the ED
  • Explain: 
       The 5 minute neurological exam 
       How to dissect dizziness 
       The current standard of care for treating TIA and stroke 
       Imaging and thrombolysis
  • Define who is tracking your performance and what they are publishing about it

Pre-Con I Program Committee

The American Heart Association/American Stroke Association is grateful to the members of the ISC Pre-Conference Symposium I 2014 Program Committee for their dedication and leadership provided throughout the year in planning the program:

Ted Wein, MD, FRCPC, FAHA, Chair
Joshua Goldstein, MD, PhD, FAHA
Kama Guluma, MD
Brett M Kissela, MD, MS
Phillip Scott, MD, FAHA
Kyra Becker, MD, FAHA (ISC Program Committee, Vice Chair)
Steven M Greenberg, MD, PhD, FAHA (ISC Program Committee, Chair)


 
ISC PRE-CONFERENCE SYMPOSIUM II: (STUDENT/TRAINEE/EARLY CAREER): ANIMAL MODELS 2.0: CO-MORBID CONDITIONS, OPTOGENETICS AND OTHER NEW DIRECTIONS

The pre-clinical modeling of stroke occupies a key phase in the translational science of stroke therapeutics. Pre-clinical modeling of stroke serves as the primary avenue for discovery of new biological processes in cell death and neural repair. Pre-clinical modeling also serves in the intermediate stages of drug development. As the clinical science of stroke evolves, so, too, does the pre-clinical science in animal modeling of stroke. Pre-clinical models of stroke have evolved to include the effects of age, female sex, and co-morbid conditions such as diabetes. Outcome measures in pre-clinical models have grown more sophisticated than the simple observation of posture and gross movement patterns to include measures of skilled motor function and effects of repetitive motor use as might occur in neurorehabilitation. Finally, a key step in the translation of therapeutics toward human use has traditionally been the large animal model. Despite any individual or small-scale research reports, a alidated large animal model of stroke and stroke ecovery has only recently been developed.

This pre-conference course on new developments in animal modeling of stroke will provide a direct and interactive symposia with highly published investigators in the field that have developed new stroke models with these next generation of advancements.

Pre-Conference Symposium II Programming   |   Learning Objectives   |   Program Committee
CME Information


ISC 2014 Pre-Con Symposium II (Student/Trinee/Early Career): Animal Models 2.0: Co-morbid Conditions, Optogenetics and Other New Directions


Moderator: S Thomas Carmichael, MD, PhD, Los Angeles, CA

1:00   Overview and Introduction
         S Thomas Carmichael, MD, PhD, Los Angeles, CA

1:05   Female Sex and Age in Animal Models of Stroke
         
Louise D McCullough, MD, PhD, Farmington, CT

1:40   New and More Sophisticated Pre-c linical Stroke Outcome Measures
         
Theresa A Jones, PhD, Austin, TX

2:15   In Vivo Imaging of Stroke Damage and Recovery
         Craig E Brown, MD, Victoria, BC, Canada

2:50   Primate Models of Stroke Neuroprotection and Neural Repair
        
 DJ Cook, Kingston, MD, ON, Canada

3:25   Discussion


 Learning Objectives

After participating in this activity, participants will be able to:
  • Cite the goals in using pre-clinical models of stroke
  • Identify the current animal models of stroke and their limitations
  • Explain the inclusion of age, female sex, and diabetes in stroke animal modeling
  • Discuss new motor and somatosensory outcome measures in rodent models of stroke
  • Describe the role and application of large animal models of stroke

 Pre-Con II Program Committee

The American Heart Association/American Stroke Association is grateful to the members of the ISC Pre-Conference Symposium II 2014 Program Committee for their dedication and leadership provided throughout the year in planning the program:

S Thomas Carmichael, MD, PhD, Chair
Kyra Becker, MD, FAHA (ISC Program Committee, Vice Chair)
Steven M Greenberg, MD, PhD, FAHA (ISC Program Committee, Chair)


CME Information

Continuing Medical Education Accreditation - Physicians
The American Heart Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Continuing Medical Education Accreditation – Physician Assistants
AAPA accepts Category I credit from AOACCME, Prescribed credit from AAFP, and AMA PRA Category 1 Credit™ from organizations accredited by ACCME.
 
All persons who develop and/or control educational content in CME/CE activities sponsored by the American Heart Association will disclose to the audience all financial relationships with any commercial supporters of this activity as well as with other commercial interests whose lines of business are related to the CME/CE-certified content of this activity. In addition, presenters will disclose unlabeled/unapproved uses of drugs or devices discussed in their presentations. Such disclosures will be made in writing in course presentation materials.